Business
Protext Mobility Discusses Potential Effectiveness of Phytofare Green Tea Extract in Treating Type II Diabetes
Protext Mobility Discusses Potential Effectiveness of Phytofare Green Tea Extract in Treating Type II Diabetes.
About this update from Protext Mobility, Inc.
[{"type":"text","content":"\n \n \n Protext Mobility Discusses Potential Effectiveness of Phytofare Green Tea Extract in Treating Type II Diabetes\n \n \nProtext Mobility Discusses Potential Effectiveness of Phytofare Green Tea Extract in Treating Type II Diabetes\n \n BOCA RATON, FL--(Marketwired - Mar 7, 2017) - Protext Mobility, Inc. (OTC PINK: TXTM) (\"Protext\" or \"the Company\"), a biotech company engaged in the development of pharmaceutical applications for the highly bioavailable Phytofare® catechin complex today discussed the potential for Phytofare® in treating type II Diabetes. Data from in vitro and in vivo studies suggest that green tea catechins, in particularly EGCG, exert anti-obesity effects via several mechanisms including inhibition of adipocyte differentiation and proliferation, reduction of fat absorption, and the reduction in fat mass, tricylglycerides, free fatty acids and total cholesterol. The majority of human intervention studies investigating glucose homeostasis further demonstrate improved glucose levels in response to green tea catechins with potential anti-obesity, anti-diabetic and cardio-protective applications. The greatly improved absorption (bioavailability) of Phytofare® should address the blood plasma barrier issues to help regulate the metabolic issues associated with type II Diabetes.\n Phytofare® catechin complex (Phytofare®), the Company's main product, is a highly-bioavailable extract produced from live green tea leaves. Phytofare® carries distinctly unique properties over traditional green tea extracts, which is accomplished through a proprietary manufacturing process using live plants that enter the production facility within an hour of being harvested. Through this production process, Phytofare® as an end product contains all eight catechins (antioxidants) found in green tea and has been clinically researched to be efficiently transferred into the blood plasma, where the catechins have remained for more than 24 hours. Additionally, Phytofare® has 10x the bioavailability over traditionally consumed green tea resulting in a daily dosage that can deliver a therapeutic amount of catechins. In looking for a natural solution, epidemiological evidences indicate that populations with a high intake of green tea catechins benefit in terms of body weight, body ...